These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 25817856

  • 1. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
    Takamatsu Y, Hagino Y, Sato A, Takahashi T, Nagasawa SY, Kubo Y, Mizuguchi M, Uhl GR, Sora I, Ikeda K.
    Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.
    Neuroscience; 2010 Jun 02; 167(4):1183-91. PubMed ID: 20211696
    [Abstract] [Full Text] [Related]

  • 3. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ.
    Neurosci Lett; 2011 Oct 17; 504(1):35-9. PubMed ID: 21907264
    [Abstract] [Full Text] [Related]

  • 4. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T.
    J Neurochem; 2010 Jul 17; 114(1):259-70. PubMed ID: 20403082
    [Abstract] [Full Text] [Related]

  • 5. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K.
    Eur J Nucl Med; 2000 Oct 17; 27(10):1518-24. PubMed ID: 11083541
    [Abstract] [Full Text] [Related]

  • 6. Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.
    dos Santos Pereira M, Sathler MF, Valli Tda R, Marques RS, Ventura AL, Peccinalli NR, Fraga MC, Manhães AC, Kubrusly R.
    PLoS One; 2015 Oct 17; 10(10):e0141249. PubMed ID: 26509840
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of the Thyroid Hormone-Responsive (THRSP) Gene in the Striatum Leads to the Development of Inattentive-like Phenotype in Mice.
    Custodio RJP, Botanas CJ, de la Peña JB, Dela Peña IJ, Kim M, Sayson LV, Abiero A, Ryoo ZY, Kim BN, Kim HJ, Cheong JH.
    Neuroscience; 2018 Oct 15; 390():141-150. PubMed ID: 30138648
    [Abstract] [Full Text] [Related]

  • 8. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T, Kojima T, Honda Y, Hosokawa T, Tsutsui KI, Watanabe M.
    J Neurosci; 2017 Mar 01; 37(9):2387-2394. PubMed ID: 28154152
    [Abstract] [Full Text] [Related]

  • 9. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N, Fryer TD, Hong YT, Smith R, Brichard L, Acosta-Cabronero J, Chamberlain SR, Tait R, Izquierdo D, Regenthal R, Dowson J, Suckling J, Baron JC, Aigbirhio FI, Robbins TW, Sahakian BJ, Müller U.
    Brain; 2013 Nov 01; 136(Pt 11):3252-70. PubMed ID: 24163364
    [Abstract] [Full Text] [Related]

  • 10. Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors.
    Andersen SL, Napierata L, Brenhouse HC, Sonntag KC.
    Eur J Neurosci; 2008 Jun 01; 27(11):2962-72. PubMed ID: 18588536
    [Abstract] [Full Text] [Related]

  • 11. Aberrant regulation of synchronous network activity by the attention-deficit/hyperactivity disorder-associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex.
    Zhong P, Liu W, Yan Z.
    J Physiol; 2016 Jan 01; 594(1):135-47. PubMed ID: 26541360
    [Abstract] [Full Text] [Related]

  • 12. Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD.
    Schecklmann M, Schaldecker M, Aucktor S, Brast J, Kirchgässner K, Mühlberger A, Warnke A, Gerlach M, Fallgatter AJ, Romanos M.
    J Psychiatr Res; 2011 Nov 01; 45(11):1463-70. PubMed ID: 21689828
    [Abstract] [Full Text] [Related]

  • 13. Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder.
    Rubia K, Halari R, Cubillo A, Smith AB, Mohammad AM, Brammer M, Taylor E.
    Neuropsychopharmacology; 2011 Jul 01; 36(8):1575-86. PubMed ID: 21451498
    [Abstract] [Full Text] [Related]

  • 14. Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder.
    Fernández G, Krapacher F, Ferreras S, Quassollo G, Mari MM, Pisano MV, Montemerlo A, Rubianes MD, Bregonzio C, Arias C, Paglini MG.
    Exp Neurol; 2021 Dec 01; 346():113866. PubMed ID: 34537209
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate.
    Federici M, Latagliata EC, Ledonne A, Rizzo FR, Feligioni M, Sulzer D, Dunn M, Sames D, Gu H, Nisticò R, Puglisi-Allegra S, Mercuri NB.
    J Biol Chem; 2014 Jan 03; 289(1):264-74. PubMed ID: 24280216
    [Abstract] [Full Text] [Related]

  • 16. Developmental nicotine exposure precipitates multigenerational maternal transmission of nicotine preference and ADHD-like behavioral, rhythmometric, neuropharmacological, and epigenetic anomalies in adolescent mice.
    Buck JM, Sanders KN, Wageman CR, Knopik VS, Stitzel JA, O'Neill HC.
    Neuropharmacology; 2019 May 01; 149():66-82. PubMed ID: 30742847
    [Abstract] [Full Text] [Related]

  • 17. Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.
    Drerup JM, Hayashi K, Cui H, Mettlach GL, Long MA, Marvin M, Sun X, Goldberg MS, Lutter M, Bibb JA.
    Biol Psychiatry; 2010 Dec 15; 68(12):1163-71. PubMed ID: 20832057
    [Abstract] [Full Text] [Related]

  • 18. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.
    Arch Gen Psychiatry; 2007 Aug 15; 64(8):932-40. PubMed ID: 17679638
    [Abstract] [Full Text] [Related]

  • 19. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
    Yan TC, McQuillin A, Thapar A, Asherson P, Hunt SP, Stanford SC, Gurling H.
    J Psychopharmacol; 2010 Jan 15; 24(1):27-38. PubMed ID: 19204064
    [Abstract] [Full Text] [Related]

  • 20. A role for cortical dopamine in the paradoxical calming effects of psychostimulants.
    Harris SS, Green SM, Kumar M, Urs NM.
    Sci Rep; 2022 Feb 24; 12(1):3129. PubMed ID: 35210489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.